These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 29564772)

  • 41. Heterochromatin delays CRISPR-Cas9 mutagenesis but does not influence the outcome of mutagenic DNA repair.
    Kallimasioti-Pazi EM; Thelakkad Chathoth K; Taylor GC; Meynert A; Ballinger T; Kelder MJE; Lalevée S; Sanli I; Feil R; Wood AJ
    PLoS Biol; 2018 Dec; 16(12):e2005595. PubMed ID: 30540740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome Editing in Mouse Embryos with CRISPR/Cas9.
    Scott GJ; Gruzdev A
    Methods Mol Biol; 2019; 1960():23-40. PubMed ID: 30798518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modification of the Genome of Domestic Animals.
    Lotti SN; Polkoff KM; Rubessa M; Wheeler MB
    Anim Biotechnol; 2017 Jul; 28(3):198-210. PubMed ID: 28103141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted Gene Editing in Human Pluripotent Stem Cells Using Site-Specific Nucleases.
    Merkert S; Martin U
    Adv Biochem Eng Biotechnol; 2018; 163():169-186. PubMed ID: 29124278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exogenous gene integration mediated by genome editing technologies in zebrafish.
    Morita H; Taimatsu K; Yanagi K; Kawahara A
    Bioengineered; 2017 May; 8(3):287-295. PubMed ID: 28272984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of CRISPR-Cas system in gene therapy: Pre-clinical progress in animal model.
    Guan L; Han Y; Zhu S; Lin J
    DNA Repair (Amst); 2016 Oct; 46():1-8. PubMed ID: 27519625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The genome editing revolution: A CRISPR-Cas TALE off-target story.
    Stella S; Montoya G
    Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of the CRISPR/Cas System for Generation of Pathogen-Resistant Plants.
    Makarova SS; Khromov AV; Spechenkova NA; Taliansky ME; Kalinina NO
    Biochemistry (Mosc); 2018 Dec; 83(12):1552-1562. PubMed ID: 30878030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genome Editing of Silkworms.
    Tsubota T; Sakai H; Sezutsu H
    Methods Mol Biol; 2023; 2637():359-374. PubMed ID: 36773160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing.
    Liu B; Chen S; Rose A; Chen D; Cao F; Zwinderman M; Kiemel D; Aïssi M; Dekker FJ; Haisma HJ
    Nucleic Acids Res; 2020 Jan; 48(2):517-532. PubMed ID: 31799598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair.
    Jasin M; Haber JE
    DNA Repair (Amst); 2016 Aug; 44():6-16. PubMed ID: 27261202
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Ma X; Wong AS; Tam HY; Tsui SY; Chung DL; Feng B
    Zool Res; 2018 Mar; 39(2):58-71. PubMed ID: 29515088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genome Editing in Stem Cells for Disease Therapeutics.
    Song M; Ramakrishna S
    Mol Biotechnol; 2018 Apr; 60(4):329-338. PubMed ID: 29516417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PLANTS IN THE CRISPR.
    Webb S
    Biotechniques; 2017 Sep; 63(3):96-101. PubMed ID: 28911311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Editing the genome of hiPSC with CRISPR/Cas9: disease models.
    Bassett AR
    Mamm Genome; 2017 Aug; 28(7-8):348-364. PubMed ID: 28303292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Manipulating the Biosynthesis of Bioactive Compound Alkaloids for Next-Generation Metabolic Engineering in Opium Poppy Using CRISPR-Cas 9 Genome Editing Technology.
    Alagoz Y; Gurkok T; Zhang B; Unver T
    Sci Rep; 2016 Aug; 6():30910. PubMed ID: 27483984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved Genome Editing in the Ascidian Ciona with CRISPR/Cas9 and TALEN.
    Sasakura Y; Horie T
    Methods Mol Biol; 2023; 2637():375-388. PubMed ID: 36773161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.